; and (ii) at appropriate, evidence-based intervals (and in no case less than once every 30 days) after the first day on which such services are provided to the individual, is subsequently reassessed and determined to continue to require such services to promote the individual's recovery and stable transition to ongoing treatment in an outpatient setting; and (B) in a facility that— (i) is licensed by the Single State Agency for Substance Abuse Services of the State in which it is located; (ii) is accredited for the treatment of substance use disorders by the Joint Commission, the Commission on Accreditation of Rehabilitation Facilities, the Council on Accreditation, or any other accrediting agency that the Secretary deems appropriate as necessary to ensure nationwide applicability; (iii) employs a provider who can prescribe and discuss with patients the risks, benefits, and alternatives of at least 2 forms of medications approved by the Food and Drug Administration to treat substance use disorder involving opioids, including one antagonist and one partial agonist